Spotlight on Macular Degeneration
On April 29, 2009, the CIRM Governing Board heard from four speakers about the promise of stem cell research in treating macular degeneration. Carmen Puliafito presented a brief overview of macular degeneration, Sharon Hayes provided a patient’s perspective of macular degeneration, David Hinton described the generation of retinal epithelium cells from human embryonic stem cells for use in cell replacement therapy, and Mark Humayun outlined clinical treatment strategies for age-related macular degeneration.
- Welcoming remarks: Robert Klein, J.D., Chair of the Governing Board and Carmen Puliafito, M.D., M.B.A., member of the CIRM Governing Board and dean of the Keck School of Medicine of USC
- Sharon Hayes, patient with macular degeneration
- David Hinton, M.D., professor of pathology, Keck School of Medicine of USC
- Mark Humayun, M.D., professor of ophthalmology, Keck School of Medicine of USC